ArticleFrontiers in immunology2024

Survival benefit of combined immunotherapy and chemoradiotherapy in locally advanced unresectable esophageal cancer: an analysis based on the SEER database.

Liangyun Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.